In late 2025 and early 2026, the FDA removed the “black box” warning label found on certain menopausal hormone therapy products, including estrogen patches. The removal of this warning paired with a surge in demand for medications for perimenopause and menopause has resulted in a shortage of estrogen patches, leaving many patients scrambling. Dr. Nesreen Hermes, a family medicine doctor in Illinois who regularly sees patients for perimenopause and menopausal symptoms, joined ForbesWomen editor Maggie McGrath to discuss. Learn more about your ad choices. Visit megaphone.fm/adchoices